cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Inovio Pharmaceuticals Inc
114 own
73 watching
Current Price
$1.91
$0.12
(6.7%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
476.52M
52-Week High
52-Week High
4
52-Week Low
52-Week Low
1.38
Average Volume
Average Volume
8.76M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization476.52M
icon52-Week High4
icon52-Week Low1.38
iconAverage Volume8.76M
iconDividend Yield--
iconP/E Ratio--
What does the Inovio Pharmaceuticals Inc do?
Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system's tolerance of cancerous cells; and SynCon product design is also intended to facilitate cross-strain protection against known, as well as new unmatched strains of pathogens, such as influenza. It has completed, current or planned clinical programs of its proprietary SynCon immunotherapies for HPV-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus, hepatitis B virus, HIV, Ebola, Middle East Respiratory Syndrome, and Zika virus. The company's partners and collaborators include MedImmune, LLC, the Wistar Institute, University of Pennsylvania, Defense Advanced Research Projects Agency, GeneOne Life Science, Plumbline Life Sciences, ApolloBio Corporation, Drexel University, the National Institutes of Health, HIV Vaccines Trial Network, National Cancer Institute, and U.S. Military HIV Research Program. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
Read More
How much money does Inovio Pharmaceuticals Inc make?
News & Events about Inovio Pharmaceuticals Inc.
PR Newswire
1day ago
INOVIO Reports Inducement Grants Under Inducement Plan INOVIO Reports Inducement Grants Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Feb. 3, 2023 PLYMOUTH MEETING, Pa., Feb. 3, 2023 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing...
PR Newswire
2 months ago
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants PR Newswire PALM BEACH, Fla., Nov. 16, 2022 FinancialNewsMedia.com News Commentary PALM BEACH...
Ticker Report
4 months ago
Hennion Walsh Asset Management Inc. increased its stake in shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO Get Rating) by 4.5% in the 2nd quarter, according to the company in its most recent filing with the Securities Exchange Commission. The fund owned 361,196 shares of the ...
Zolmax
5 months ago
WINTON GROUP Ltd increased its holdings in Inovio Pharmaceuticals, Inc. (NASDAQ:INO Get Rating) by 30.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,156 shares of the biopharmaceutical ...
Frequently Asked Questions
Frequently Asked Questions
What is Inovio Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Inovio Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Inovio Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Inovio Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Inovio Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Inovio Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Inovio Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Inovio Pharmaceuticals Inc?
plus_minus_icon
What percentage is Inovio Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Inovio Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.91
$0.12
(6.7%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00